Fig. 2

Network diagrams for primary and secondary outcomes. Illustration of networks for each network meta-analysis. Each treatment node indicates an intervention and is weighted according to the number of patients who received the particular intervention. Each edge (line connecting the nodes) is weighted according to the number of studies that directly compare the treatments it connects. Abbreviations: AFLI, aflibercept; BEVA, bevacizumab; BROL, brolucizumab; CONB, conbercept; DXM, dexamethasone; IVTA, intravitreal triamcinolone acetonide; PDT, photodynamic therapy; PLAC, placebo; RANI, ranibizumab